Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
112023_CP_Succes_de_l_augmentation_de_capital_FR
By
admin
November 19, 2023
231106_PR_Participation_BIO-Europe_EN
By
admin
November 6, 2023
231106_CP_Participation_BIO-Europe_FR
By
admin
November 6, 2023
BIOPHYTIS_Code_de_conduite_professionnelle_et_d_ethique_2023
By
admin
November 3, 2023
BIOPHYTIS_Code_of_Business_Conduct_and_Ethics_2023
By
admin
November 3, 2023
233010_PR_Partnership-ISP_Brazil
By
admin
October 29, 2023
233010_CP_Partenariat_PAE_Bresil
By
admin
October 29, 2023
231027_PR_Delisting_notice_Nasdaq
By
admin
October 27, 2023
231027_CP_Avis_de_radiation_du_Nasdaq
By
admin
October 27, 2023
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
…
30
31
32
33
34
←
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
